Stay updated with breaking news from Intermountain Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By revealing how tumors interact with immune cells, Noetik aims to identify new targets for new cancer drugs. The startup and its artificial intelligence-driven platform are supported by $14 million in seed financing.
Earlier this year, the venture capital firm told its portfolio companies to buckle down. Now it’s doing the same.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
By Daniella Parra Octave Bioscience said it secured a $30 million extension to its Series B funding round. The investment, led by Novartis, Hikma Ventures and Intermountain Ventures, will accelerate commercialization of their precision care solution for multiple sclerosis (MS) and other neurodegenerative diseases, the company said in a statement. “The strength and breadth of […]
/PRNewswire/ -- Leiters, a trusted FDA-registered 503B outsourcing provider of high-quality compounded sterile preparations and pharmacy services, announced...